Redcare Pharmacy NV (ETR:RDC)

Redcare Pharmacy NV Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	96.89	84.16	66.78	247.41	90.49
Short-Term Investments	80.66	120	113.32	36.42	37.77
Cash & Short-Term Investments	177.56	204.16	180.1	283.83	128.26
Cash Growth	-13.03%	13.36%	-36.55%	121.30%	13.27%
Accounts Receivable	109.87	103.13	30	27.92	29.98
Other Receivables	14.99	16.17	10.94	8.25	-
Receivables	124.86	119.31	40.95	36.16	29.98
Inventory	153.82	135.79	99.71	96.62	81.24
Prepaid Expenses	17.99	10.89	6.57	3.7	4.71
Other Current Assets	25.79	29.38	16.59	12.45	9.91
Total Current Assets	500.02	499.52	343.92	432.76	254.09
Property, Plant & Equipment	82.57	86.91	85.44	78.26	74.55
Long-Term Investments	1.42	1.31	1.27	1.47	1.77
Goodwill	277.5	277.5	169.57	153.13	129.12
Other Intangible Assets	133.82	150.61	119.43	104.35	75.54
Long-Term Deferred Tax Assets	1.41	2.3	0.46	-	0.12
Other Long-Term Assets	6.55	3.46	9.39	13.11	1.73
Total Assets	1,003	1,022	729.47	783.08	536.91
Accounts Payable	175.29	152	68.94	78.12	51.32
Accrued Expenses	55.56	56.79	38.64	36.38	15.65
Short-Term Debt	-	-	-	0.04	0.04
Current Portion of Long-Term Debt	1.63	1.63	1.67	1.63	-
Current Portion of Leases	8.1	7.15	5.88	4.74	5.38
Current Income Taxes Payable	0.46	0.57	0.24	0.78	0.39
Other Current Liabilities	8.7	5.6	3.94	2.41	1.82
Total Current Liabilities	249.73	223.72	119.31	124.09	74.61
Long-Term Debt	209.14	204.35	199.75	195.38	4.08
Long-Term Leases	27.68	30.68	27.59	26.06	28.73
Long-Term Deferred Tax Liabilities	3.57	6.32	7.89	13.55	4.35
Other Long-Term Liabilities	-	-	14.62	2.65	-
Total Liabilities	493.32	469.56	374.84	367.66	111.77
Common Stock	0.4	0.4	0.36	0.36	0.35
Additional Paid-In Capital	754.9	733.03	570.7	566.54	551.67
Retained Earnings	-324.29	-279.26	-285.43	-207.78	-133.72
Comprehensive Income & Other	52.97	68.03	69	56.3	6.84
Total Common Equity	483.98	522.19	354.63	415.41	425.14
Minority Interest	25.99	29.84	-	-	-
Shareholders' Equity	509.97	552.03	354.63	415.41	425.14
Total Liabilities & Equity	1,003	1,022	729.47	783.08	536.91
Total Debt	246.54	243.79	234.89	227.84	38.23
Net Cash (Debt)	-68.99	-39.63	-54.79	55.99	90.02
Net Cash Growth	-	-	-	-37.80%	-
Net Cash Per Share	-3.44	-2.06	-3.05	3.13	6.26
Filing Date Shares Outstanding	20.34	20.2	18.2	18.1	17.94
Total Common Shares Outstanding	20.34	20.2	18.2	18.1	17.94
Working Capital	250.29	275.79	224.61	308.68	179.47
Book Value Per Share	23.79	25.85	19.49	22.96	23.70
Tangible Book Value	72.67	94.09	65.63	157.94	220.48
Tangible Book Value Per Share	3.57	4.66	3.61	8.73	12.29
Land	6.61	5.3	6.43	37.88	40.95
Machinery	53.45	49.74	43.53	35.25	12.29
Construction In Progress	1.06	0.73	3.82	5.92	22.29

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.